.svg){kind=small}
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeMarket Insights Snapshot
Amend Cannabis concentrated 75.33% of October 2026 sales in Topical, up 191.14% month over month, while Tincture & Sublingual held 24.67% with a 10.09% MoM decline; within Topical, the average price sat at $41.88 versus $30.16 in Tincture & Sublingual, indicating a higher-ticket anchor as mix skews toward Topical. With a 24-month sales change of -28.02% alongside a current Topical rank of 6 in Missouri, the steep MoM acceleration in Topical and concurrent Tincture & Sublingual pullback imply the brand is trading volume into a narrower, higher-priced lane rather than broadening across formats.
The shift toward a 75.33% Topical mix and a 191.14% MoM lift, coupled with a 10.09% MoM contraction in Tincture & Sublingual and a category rank of 6 in Missouri, suggests the brand is leaning into a defensible niche where rank momentum can be leveraged for visibility. Given a -28.02% sales change over 24 months and a $41.88 Topical price point against a $30.16 alternative, the pattern implies a positioning bet on premiumized Topical depth to stabilize share, accepting near-term exposure to category concentration risk if Topical growth normalizes.
Competitive Landscape
Amend Cannabis sits at rank #6 in MO Topical for October 2026, up 3 positions from #9 in July 2026, while its all-time peak was #5 in October 2024; in contrast, Mary's Medicinals holds #1 with a -13.96% year-over-year sales change and Escape Artists is #2 with a -14.20% year-over-year change, indicating that Amend Cannabis’s recent rank gain comes as category leaders contract and Vlasic Labs advances from #6 to #4 with a 10.50% year-over-year sales increase; the pattern implies Amend Cannabis is capitalizing on short-term share openings but must convert the 3-rank climb into sustained momentum to surpass its October 2024 peak.
Notable Products
Amend Cannabis is highly concentrated in October 2026, with CBD/THC 1:1 Amend Infused Balm (250mg CBD, 250mg THC) accounting for 73.4% of sales and the Topical Lip Balm segment matching that 73.4% share, so most of its sales ride on a single balm format.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
